Research method
ELISA
3 studies
ELISA (enzyme-linked immunosorbent assay) quantifies a soluble antigen, antibody, or metabolite by capturing it on a plate and reading an enzyme-linked colour or fluorescence signal. The output is a concentration relative to a standard curve, not a trafficking movie and not a sequence. Cross-reactive antibodies and the choice of what is being captured (ligand, cytokine, viral antigen) decide the biological meaning.
Infection and receptor papers reach for ELISA when they need a bulk concentration — a cytokine, a circulating ligand, or a viral/antibody titre — rather than a single-cell image. It answers 'how much of this epitope is in the well or the serum?' Its main limitation is that none of the three papers tagged here describe ELISA as the headline method; the summaries are trafficking genetics, vaccine-virulence experiments, and OMV–epithelium signalling, so ELISA is at most a supporting readout.
Studies
3
Findings
3
3 supporting · 0 challenging · 0 qualifying citations
Open tensions
2
Currently
What we know
- Human MC4R variants were assayed in cells for surface expression, endocytosis/trafficking, dimerization, β-arrestin engagement and ERK/cAMP signalling. MC4R homodimerizes and undergoes β-arrestin-2–driven endocytosis; many variants impair trafficking even when cAMP looks normal, and gain-of-function alleles link to obesity protection. Any ELISA-format cAMP or ligand-binding plate is a supporting biochemistry assay, not the core trafficking microscopy, and cellular loss-of-function is not a clinical trial.
- Leaky Marek's disease vaccines in chickens prolonged infectious periods by about 2 weeks, sped sentinel infection by about 9 days, and allowed hyperpathogenic strains that kill unvaccinated birds at up to 100% to be maintained. Shedding and sentinel infection are the endpoints; plate immunoassays, if used for virus or antibody, are not described as the intellectual core, and the experiment shows vaccines can maintain hypervirulent strains rather than that vaccines historically caused MDV evolution by themselves.
- Outer-membrane vesicles from probiotic and commensal E. coli carry peptidoglycan ligands for NOD1/NOD2, enabling bacteria–host communication across mucus and modulating epithelial innate responses and barrier functions. Cytokine ELISA is a common supporting readout for those epithelial responses, but the paper is a vesicle–PRR mechanism study, not a clinical probiotic trial and not an ELISA-methods paper.
Largest unresolved question
The three tagged studies disagree about what an 'ELISA paper' would even be measuring. MC4R work is cellular receptor trafficking and cAMP/ERK; MDV work is shedding, infectious period (~2 weeks) and sentinel timing (~9 days earlier) in chickens; E. coli OMV work is NOD1/NOD2 ligands and epithelial barrier signalling. They share an immunoassay-shaped supporting assay at most, not a common antigen.
Common misconceptions
If an MC4R variant looks normal in a cAMP ELISA-style well, the receptor traffics normally.
Many variants impair surface expression, endocytosis or dimerization even when cAMP looks normal. Plate pathway readouts miss trafficking-defective alleles; gain-of-function alleles link to obesity protection through other properties.
Because vaccinated chickens can shed hyperpathogenic MDV, vaccines have been proven to be the historical cause of MDV evolution.
Vaccination prolonged infectious periods (~2 weeks), sped sentinel infection (~9 days earlier), and can maintain strains that kill unvaccinated birds at up to 100%. That shows a mechanism for maintaining hypervirulent strains, not that vaccines alone historically caused MDV evolution.
An epithelial cytokine ELISA after E. coli OMVs is a clinical probiotic outcome.
OMVs carry NOD1/NOD2 peptidoglycan ligands and modulate epithelial innate responses and barrier function in cell systems. That is not a full clinical probiotic trial in patients.
Related
Claim ledger
What the evidence shows
Drawn from 3 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Human MC4R variants were assayed in cells for surface expression, endocytosis/trafficking, dimerization, β-arrestin engagement and ERK/cAMP signalling. MC4R homodimerizes and undergoes β-arrestin-2–driven endocytosis; many variants impair trafficking even when cAMP looks normal, and gain-of-function alleles link to obesity protection. Any ELISA-format cAMP or ligand-binding plate is a supporting biochemistry assay, not the core trafficking microscopy, and cellular loss-of-function is not a clinical trial.
Leaky Marek's disease vaccines in chickens prolonged infectious periods by about 2 weeks, sped sentinel infection by about 9 days, and allowed hyperpathogenic strains that kill unvaccinated birds at up to 100% to be maintained. Shedding and sentinel infection are the endpoints; plate immunoassays, if used for virus or antibody, are not described as the intellectual core, and the experiment shows vaccines can maintain hypervirulent strains rather than that vaccines historically caused MDV evolution by themselves.
Outer-membrane vesicles from probiotic and commensal E. coli carry peptidoglycan ligands for NOD1/NOD2, enabling bacteria–host communication across mucus and modulating epithelial innate responses and barrier functions. Cytokine ELISA is a common supporting readout for those epithelial responses, but the paper is a vesicle–PRR mechanism study, not a clinical probiotic trial and not an ELISA-methods paper.
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
The three tagged studies disagree about what an 'ELISA paper' would even be measuring. MC4R work is cellular receptor trafficking and cAMP/ERK; MDV work is shedding, infectious period (~2 weeks) and sentinel timing (~9 days earlier) in chickens; E. coli OMV work is NOD1/NOD2 ligands and epithelial barrier signalling. They share an immunoassay-shaped supporting assay at most, not a common antigen.
The three tagged studies disagree about what an 'ELISA paper' would even be measuring. MC4R work is cellular receptor trafficking and cAMP/ERK; MDV work is shedding, infectious period (~2 weeks) and sentinel timing (~9 days earlier) in chickens; E. coli OMV work is NOD1/NOD2 ligands and epithelial barrier signalling. They share an immunoassay-shaped supporting assay at most, not a common antigen.
- How MC4R variants scramble receptor trafficking
- Can leaky vaccines favor nastier viruses?
- How do E. coli vesicles talk to gut epithelium?
Study Role Design N Population Outcome How MC4R variants scramble receptor trafficking Supports Animal / in-vitroCell assays of rare and common human MC4R variants for trafficking, dimerization, and signaling N=48 · 48 rare obesity-associated MC4R variants plus two common protective alleles (V103I, I251L) Human MC4R variants expressed in cellular assays Endocytosis, trafficking, dimerization, and signaling consequences of MC4R variants Can leaky vaccines favor nastier viruses? Supports Animal / in-vitroExperimental MDV infection of vaccinated vs unvaccinated chicks with shedding and sentinel transmission assays Multiple experiments (e.g., n=200, 120, 60 vaccinated + 60 maternal-Ab groups) — no single primary N One-day-old chicks infected with Marek's disease virus strains Infectious period, shedding, and sentinel infection under imperfect vaccination How do E. coli vesicles talk to gut epithelium? Supports Animal / in-vitroOMVs from probiotic/commensal E. coli tested on intestinal epithelial innate sensors (NOD1) Caco-2/HT-29 cell assays — no single primary analytic N Human intestinal epithelial cell lines exposed to E. coli OMVs NOD1-dependent epithelial innate responses to bacterial OMVs
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Implications also conflict if someone treats every plate assay as the same. A normal cAMP well for an MC4R variant can hide a trafficking defect relevant to obesity genetics; a high viral titre after leaky vaccination can hide increased transmission of hyperpathogenic MDV; an epithelial cytokine bump after OMVs is not probiotic efficacy in patients.
Implications also conflict if someone treats every plate assay as the same. A normal cAMP well for an MC4R variant can hide a trafficking defect relevant to obesity genetics; a high viral titre after leaky vaccination can hide increased transmission of hyperpathogenic MDV; an epithelial cytokine bump after OMVs is not probiotic efficacy in patients.
- How MC4R variants scramble receptor trafficking
- Can leaky vaccines favor nastier viruses?
- How do E. coli vesicles talk to gut epithelium?
Study Role Design N Population Outcome How MC4R variants scramble receptor trafficking Supports Animal / in-vitroCell assays of rare and common human MC4R variants for trafficking, dimerization, and signaling N=48 · 48 rare obesity-associated MC4R variants plus two common protective alleles (V103I, I251L) Human MC4R variants expressed in cellular assays Endocytosis, trafficking, dimerization, and signaling consequences of MC4R variants Can leaky vaccines favor nastier viruses? Supports Animal / in-vitroExperimental MDV infection of vaccinated vs unvaccinated chicks with shedding and sentinel transmission assays Multiple experiments (e.g., n=200, 120, 60 vaccinated + 60 maternal-Ab groups) — no single primary N One-day-old chicks infected with Marek's disease virus strains Infectious period, shedding, and sentinel infection under imperfect vaccination How do E. coli vesicles talk to gut epithelium? Supports Animal / in-vitroOMVs from probiotic/commensal E. coli tested on intestinal epithelial innate sensors (NOD1) Caco-2/HT-29 cell assays — no single primary analytic N Human intestinal epithelial cell lines exposed to E. coli OMVs NOD1-dependent epithelial innate responses to bacterial OMVs
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
ELISA
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
Papers
3 studies in this library bear on ELISA, ordered by citations.
- Can leaky vaccines favor nastier viruses?
Imperfect Marek’s disease vaccination keeps infected chickens alive longer, boosting transmission of strains too lethal to persist without vaccines.
- How do E. coli vesicles talk to gut epithelium?
Outer membrane vesicles from probiotic and commensal E. coli deliver ligands that activate NOD1-mediated immune responses in intestinal epithelial cells.
- How MC4R variants scramble receptor trafficking
Obesity-linked MC4R mutations disrupt plasma-membrane localization, endocytosis and β-arrestin pathways beyond classical cAMP loss-of-function.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
The three tagged studies disagree about what an 'ELISA paper' would even be measuring. MC4R work is cellular receptor trafficking and cAMP/ERK; MDV work is shedding, infectious period (~2 weeks) and sentinel timing (~9 days earlier) in chickens; E. coli OMV work is NOD1/NOD2 ligands and epithelial barrier signalling. They share an immunoassay-shaped supporting assay at most, not a common antigen.
Implications also conflict if someone treats every plate assay as the same. A normal cAMP well for an MC4R variant can hide a trafficking defect relevant to obesity genetics; a high viral titre after leaky vaccination can hide increased transmission of hyperpathogenic MDV; an epithelial cytokine bump after OMVs is not probiotic efficacy in patients.
Study this conceptflashcards and short-answer questions
Why might an ELISA-format cAMP assay and a surface-expression assay disagree for the same MC4R variant?
cAMP can look normal while endocytosis, dimerization or surface delivery is impaired because β-arrestin-2–driven trafficking is a separate axis. Cellular classification still is not a clinical trial; mouse models are needed for genotype–phenotype dissection.
Leaky MDV vaccination extends infectious periods by ~2 weeks and advances sentinel infection by ~9 days. What titre-like measurement would support 'maintained hyperpathogenic strains' without proving historical vaccine-driven evolution?
Shedding and sentinel infection showing that vaccinated hosts transmit strains that kill unvaccinated birds at up to 100%. Historical causation would need epidemiological time series the experiment does not provide.
E. coli OMVs deliver peptidoglycan to NOD1/NOD2 across mucus. If a student only had an IL-8 ELISA from epithelium, what mechanistic claim would still be missing?
That the vesicles carry PRR ligands and communicate across mucus to modulate barrier function. A cytokine number alone does not identify NOD1/NOD2 or prove a probiotic trial result.
These three papers are the entire ELISA dump list. How should a student treat ELISA as a method in this set?
As a possible supporting plate readout, not the experimental design. The designs are MC4R trafficking genetics, chicken MDV transmission under leaky vaccination, and OMV–epithelial innate sensing. Do not pretend they all quantified the same analyte.